pharma news today glp-1 obesity drugs today Agonists Weight Loss Market Report, 2025-2030 GLP-1 Therapies Drive Indian Pharma
Description
While this medication remains branded, its use will be limited by its cost
In the TRIUMPH-1 Phase 3 trial, participants on the highest dose of retatrutide lost an average of 28.3% of their body weight at 80 weeks
doi: 10.1016/j.ijcard.2017.03.042
Consulta already command close to 8% of retail value in Brazil by bundling virtual consults, drug delivery, and remote monitoring
